Showing results (491-500 of 652) with videos related to

Sort By:
Pageof 66
Acta Naturae|November 9, 2022
Extracellular Vesicles Derived from Metastatic Melanoma Cells Transfer α7-nAChR mRNA, Thus Increasing the Surface Expression of the Receptor and Stimulating the Growth of Normal KeratinocytesM L Bychkov, A V Kirichenko, I N Mikhaylova, et al.
Contrast Media & Molecular Imaging|August 13, 2015
Connexin 43-targeted T1 contrast agent for MRI diagnosis of gliomaTatiana Abakumova, Maxim Abakumov, Sergey Shein, et al.
Biomolecules|December 16, 2020
Cytokinin-Regulated Expression of Arabidopsis thaliana PAP Genes and Its Implication for the Expression of Chloroplast-Encoded GenesAleksandra A Andreeva, Radomira Vankova, Ivan A Bychkov, et al.
Scientific Reports|June 8, 2023
Effect of the 2020 hypersensitivity pneumonitis guideline on the pathologic diagnosis of interstitial pneumoniaMutsumi Ozasa, Andrey Bychkov, Yoshiaki Zaizen, et al.
International Journal of Molecular Sciences|May 4, 2026
Identification and Targeted Correction of a Pathogenic PMP22 Deep Intronic VariantPolina Chausova, Aysylu Murtazina, Igor Bychkov, et al.
BMC Endocrine Disorders|May 22, 2026
Interplay of BRAF and TERT promoter mutations and Ki67 proliferation index in papillary thyroid carcinoma in Central AsiansAkbota Targynova, Zhanna Mussazhanova, Andrey Bychkov, et al.
Cureus|November 18, 2022
Correction: Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Pathology International|February 28, 2019
Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practiceZhiyan Liu, Andrey Bychkov, Chan Kwon Jung, et al.
Clinical Neurology and Neurosurgery|January 12, 2021
POLG-associated ataxias can represent a substantial part of recessive and sporadic ataxias in adultsEvgenii Nuzhnyi, Yury Seliverstov, Sergey Klyushnikov, et al.
Cureus|November 16, 2022
Phase 1 First-in-Human Dose Escalation and Dose Expansion Study of KLS-1 (64Zinc Aspartate) in Patients With Cancer and Neurodegenerative DiseasesJesus A Perez, Javier J Lopez, Claudia C Torres Badillo, et al.
Pageof 66